SurgePays, Inc. (SURG) Stock Forecast
SURG analyst forecast
as of October 17, 2026- Analyst consensus
- Strong buy 5.00 / 5 from 1 analysts
- Price target
- $3.75 average of analyst targets
- Upside to target
- +2,924.2% from the latest close
- Next earnings
- November 11, 2026 EPS estimate $-0.07
- 52-week range
- $0.12 – $2.91
SURG analyst ratings
1 analystsNumber of analysts at each rating.
SURG price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
SURG earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.07 | −$0.07 | −$0.07 | −$0.38 | +81.6% | 1 |
| Current fiscal year (2026) | −$0.44 | −$0.44 | −$0.44 | −$1.80 | +75.6% | 1 |
| Next fiscal year (2027) | $0.01 | $0.01 | $0.01 | −$0.44 | +102.3% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
SURG revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $16.5M | $16.5M | $16.5M | −11.7% | 1 |
| Current fiscal year (2026) | $64.9M | $64.9M | $64.9M | +13.9% | 1 |
| Next fiscal year (2027) | $70.1M | $70.1M | $70.1M | +8.0% | 1 |
SURG EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
SURG revenue: reported and forecast
SURG EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.08 | −$0.08 | −$0.08 | −$0.08 | −$0.07 | −12.5% | 1 up · 0 down |
| Current fiscal year (2026) | −$0.70 | −$0.70 | −$0.70 | −$0.70 | −$0.44 | −37.1% | 0 up · 1 down |
| Next fiscal year (2027) | $0.05 | $0.05 | $0.05 | $0.05 | $0.01 | −80.0% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
SURG earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; SURG beat in 2 of 12.
What analysts expect from SURG
1 analysts cover SurgePays; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $3.75, 2,924.2% above the latest close of $0.12. Analysts expect earnings of −$0.44 per share for 2026, +75.6% from a year earlier. For 2027 the average estimate is $0.01 per share on revenue of $70.1 million. SurgePays beat the EPS estimate in 2 of the last 12 quarters.
Related: SURG income statement, SURG key metrics, SURG chart. See the SURG stock overview for the latest quote and news.
SURG forecast FAQ
What is SurgePays's price target?
The average analyst price target for SurgePays is $3.75, 2,924.2% above the latest close of $0.12.
Is SurgePays a buy, hold or sell?
Of 1 analysts covering SurgePays, 1 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is SurgePays's EPS forecast?
Analysts forecast −$0.44 per share for 2026 (range −$0.44 to −$0.44); for 2027 the estimate is $0.01.
What is SurgePays's revenue forecast?
The average revenue estimate for 2026 is $64.9 million, growth of 13.9%; for 2027 it is $70.1 million.
When does SurgePays report earnings?
SurgePays is expected to report results for the quarter ending September 30, 2026 on November 11, 2026 before the market opens; the EPS estimate is $-0.07.
Does SurgePays usually beat earnings estimates?
SurgePays reported EPS at or above the analyst estimate in 2 of the last 12 quarters.